Genprex, Inc.

Home » Genprex, Inc.

IPO

Genprex, Inc.

Genprex is a clinical stage gene therapy company developing a new approach to treating cancer, based upon their novel proprietary technology platform, including their initial product candidate, Oncoprex immunogene therapy, or Oncoprex.

Symbol

GNPX

Price Range
$5.00 - $5.00

Anticipated Shares
1,300,000

Anticipated Date
TBD

Underwriters
Network 1 Financial

To view the prospectus for Genprex, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253